<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report a 26-month-old boy with <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> associated with <z:e sem="disease" ids="C0238111" disease_type="Disease or Syndrome" abbrv="">Lennox-Gastaut syndrome</z:e>, who developed a <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rash</z:e> and a persistent toxic <z:hpo ids='HP_0012115'>hepatitis</z:hpo> after lamotrigine was added to valproate therapy </plain></SENT>
<SENT sid="1" pm="."><plain>The patient had typical findings of both Angelman and <z:e sem="disease" ids="C0238111" disease_type="Disease or Syndrome" abbrv="">Lennox-Gastaut syndromes</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Chromosome analysis performing by FISH analysis showed a deletion in chromosome 15 (q11.2 q11.2) </plain></SENT>
<SENT sid="3" pm="."><plain>Although some cases of <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> associated with <z:e sem="disease" ids="C0238111" disease_type="Disease or Syndrome" abbrv="">Lennox-Gastaut syndrome</z:e> were reported in the literature, valproate and/or lamotrigine induced toxic <z:hpo ids='HP_0012115'>hepatitis</z:hpo> in <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> has hitherto never been described </plain></SENT>
<SENT sid="4" pm="."><plain>We conclude that VPA and LTG combination should be given with great caution or avoided in patients with <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> </plain></SENT>
</text></document>